Gegen Qinlian Decoction Attenuates High‐Fat Diet‐Induced Steatohepatitis in Rats via Gut Microbiota
Open Access
- 1 January 2018
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 7370891
Abstract
Gut microbiota play an important role in modulating energy contribution, metabolism, and inflammation, and disruption of the microbiome population is closely associated with chronic metabolic diseases, such as nonalcoholic fatty liver disease (NAFLD). Gegen Qinlian decoction (GGQLD), a well‐known traditional Chinese herbal medicine (CHM), was previously found to regulate lipid metabolism and attenuate inflammation during NAFLD pathogenesis. However, the underlying mechanism of this process, as well as how the gut microbiome is involved, remains largely unknown. In this study, we investigated the effect of varying doses of GGQLD on the total amount and distribution of gut bacteria in rats fed a high‐fat diet (HFD) for 8 weeks. Our analysis indicates that Oscillibacter and Ruminococcaceae_g_unclassified are the dominant families in the HFD group. Further, HFD‐dependent differences at the phylum, class, and genus levels appear to lead to dysbiosis, characterized by an increase in the Firmicutes/Bacteroidetes ratio and a dramatic increase in the Oscillibacter genus compared to the control group. Treatment with GGQLD, especially the GGQLL dose, improved these HFD‐induced changes in intestinal flora, leading to increased levels of Firmicutes, Clostridia, Lactobacillus, bacilli, and Erysipelotrichales that were similar to the controls. Taken together, our data highlight the efficacy of GGQLD in treating NAFLD and support its clinical use as a treatment for NAFLD/NASH patients.Keywords
Funding Information
- National Natural Science Foundation of China (81503407)
This publication has 41 references indexed in Scilit:
- Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trialTherapeutic Advances in Gastroenterology, 2013
- Functional interactions between the gut microbiota and host metabolismNature, 2012
- The interpersonal and intrapersonal diversity of human-associated microbiota in key body sitesJournal of Allergy and Clinical Immunology, 2012
- Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Medical therapy for nonalcoholic fatty liver disease in children and adolescentsExpert Review of Gastroenterology & Hepatology, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline DeficiencyGastroenterology, 2011
- Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver diseaseCurrent Opinion in Lipidology, 2010
- Pathogenesis of non-alcoholic fatty liver diseaseQJM: An International Journal of Medicine, 2009
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology, 2008